Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 881

1.

Treating Diabetic Macular Oedema (DMO): real world UK clinical outcomes for the 0.19mg Fluocinolone Acetonide intravitreal implant (Iluvien™) at 2 years.

Fusi-Rubiano W, Mukherjee C, Lane M, Tsaloumas MD, Glover N, Kidess A, Denniston AK, Palmer HE, Manna A, Morjaria R.

BMC Ophthalmol. 2018 Feb 27;18(1):62. doi: 10.1186/s12886-018-0726-1.

2.

Fluocinolone Acetonide Intravitreal Implant 190 μg (ILUVIEN®) in Vitrectomized versus Nonvitrectomized Eyes for the Treatment of Chronic Diabetic Macular Edema.

Pessoa B, Coelho J, Correia N, Ferreira N, Beirão M, Meireles A.

Ophthalmic Res. 2018;59(2):68-75. doi: 10.1159/000484091. Epub 2017 Dec 16.

3.

A retrospective study on the outcomes of Ahmed valve versus Ahmed valve combined with fluocinolone implant in uveitic glaucoma.

Sevgi DD, Davoudi S, Talcott KE, Cho H, Guo R, Lobo AM, Papaliodis GN, Turalba A, Sobrin L, Shen LQ.

Digit J Ophthalmol. 2017 Sep 11;23(3):63-70. doi: 10.5693/djo.01.2017.06.001. eCollection 2017.

4.

Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.

Onland W, Offringa M, van Kaam A.

Cochrane Database Syst Rev. 2017 Aug 24;8:CD002311. doi: 10.1002/14651858.CD002311.pub4. Review.

PMID:
28836266
5.

Fluocinolone acetonide for the treatment of diabetic macular edema.

Veritti D, Sarao V, Diplotti L, Samassa F, Lanzetta P.

Expert Opin Pharmacother. 2017 Oct;18(14):1507-1516. doi: 10.1080/14656566.2017.1363182. Epub 2017 Aug 9. Review.

PMID:
28764565
6.

Real-world experience with 0.2 μg/day fluocinolone acetonide intravitreal implant (ILUVIEN) in the United Kingdom.

Bailey C, Chakravarthy U, Lotery A, Menon G, Talks J; Medisoft Audit Group.

Eye (Lond). 2017 Dec;31(12):1707-1715. doi: 10.1038/eye.2017.125. Epub 2017 Jul 24.

7.

Longitudinal Vision-Related Quality of Life for Patients with Noninfectious Uveitis Treated with Fluocinolone Acetonide Implant or Systemic Corticosteroid Therapy.

Sugar EA, Venugopal V, Thorne JE, Frick KD, Holland GN, Wang RC, Almanzor R, Jabs DA, Holbrook JT; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group.

Ophthalmology. 2017 Nov;124(11):1662-1669. doi: 10.1016/j.ophtha.2017.05.015. Epub 2017 Jun 16.

PMID:
28624167
8.

Association Between Long-Lasting Intravitreous Fluocinolone Acetonide Implant vs Systemic Anti-inflammatory Therapy and Visual Acuity at 7 Years Among Patients With Intermediate, Posterior, or Panuveitis.

Writing Committee for the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study Research Group, Kempen JH, Altaweel MM, Holbrook JT, Sugar EA, Thorne JE, Jabs DA.

JAMA. 2017 May 16;317(19):1993-2005. doi: 10.1001/jama.2017.5103.

9.

Fluocinolone Acetonide Intravitreal Implant 0.19 mg (ILUVIEN®): A Review in Diabetic Macular Edema.

Syed YY.

Drugs. 2017 Apr;77(5):575-583. doi: 10.1007/s40265-017-0722-4. Review.

PMID:
28283896
10.

A Nonrandomized, Open-Label, Multicenter, Phase 4 Pilot Study on the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (RESPOND).

Figueira J, Henriques J, Amaro M, Rosas V, Alves D, Cunha-Vaz J.

Ophthalmic Res. 2017;57(3):166-172. doi: 10.1159/000455235. Epub 2017 Feb 9.

PMID:
28178701
11.

Diabetic macular edema outcomes in eyes treated with fluocinolone acetonide 0.2 µg/d intravitreal implant: real-world UK experience.

El-Ghrably I, Steel DHW, Habib M, Vaideanu-Collins D, Manvikar S, Hillier RJ.

Eur J Ophthalmol. 2017 May 11;27(3):357-362. doi: 10.5301/ejo.5000929. Epub 2017 Feb 6.

PMID:
28165610
12.

Report of 12-months efficacy and safety of intravitreal fluocinolone acetonide implant for the treatment of chronic diabetic macular oedema: a real-world result in the United Kingdom.

Alfaqawi F, Lip PL, Elsherbiny S, Chavan R, Mitra A, Mushtaq B.

Eye (Lond). 2017 Apr;31(4):650-656. doi: 10.1038/eye.2016.301. Epub 2017 Jan 20.

13.

Efficacy of 0.2 μg/day fluocinolone acetonide implant (ILUVIEN) in eyes with diabetic macular edema and prior vitrectomy.

Meireles A, Goldsmith C, El-Ghrably I, Erginay A, Habib M, Pessoa B, Coelho J, Patel T, Tadayoni R, Massin P, Atorf J, Augustin AJ.

Eye (Lond). 2017 May;31(5):684-690. doi: 10.1038/eye.2016.303. Epub 2017 Jan 13.

14.

Long-term Effects of Intravitreal 0.19 mg Fluocinolone Acetonide Implant on Progression and Regression of Diabetic Retinopathy.

Wykoff CC, Chakravarthy U, Campochiaro PA, Bailey C, Green K, Cunha-Vaz J.

Ophthalmology. 2017 Apr;124(4):440-449. doi: 10.1016/j.ophtha.2016.11.034. Epub 2017 Jan 9.

PMID:
28081945
15.

Ciprofloxacin/fluocinolone (Otovel) for otitis media with tympanostomy tubes.

[No authors listed]

Med Lett Drugs Ther. 2016 Dec 5;58(1509):153-155. Review. No abstract available.

PMID:
27906149
16.

FLUOCINOLONE ACETONIDE IMPLANT FOR VOGT-KOYANAGI-HARADA DISEASE: Three-Year Outcomes of Efficacy and Safety.

Heo JW, Cho BJ, Goldstein DA, Sepah YJ, Do DV, Nguyen QD.

Retina. 2016 Nov;36(11):2124-2131.

PMID:
27333235
17.

Combined Ahmed Glaucoma Valve Placement, Intravitreal Fluocinolone Acetonide Implantation and Cataract Extraction for Chronic Uveitis.

Chang IT, Gupta D, Slabaugh MA, Vemulakonda GA, Chen PP.

J Glaucoma. 2016 Oct;25(10):842-846.

PMID:
27300641
18.

Long-term adherence to topical psoriasis treatment can be abysmal: a 1-year randomized intervention study using objective electronic adherence monitoring.

Alinia H, Moradi Tuchayi S, Smith JA, Richardson IM, Bahrami N, Jaros SC, Sandoval LF, Farhangian ME, Anderson KL, Huang KE, Feldman SR.

Br J Dermatol. 2017 Mar;176(3):759-764. doi: 10.1111/bjd.15085. Epub 2016 Nov 29.

PMID:
27664969
19.

Selective Laser Trabeculoplasty in Controlled Uveitis with Steroid-Induced Glaucoma.

Maleki A, Swan RT, Lasave AF, Ma L, Foster CS.

Ophthalmology. 2016 Dec;123(12):2630-2632. doi: 10.1016/j.ophtha.2016.07.027. Epub 2016 Sep 1. No abstract available.

PMID:
27594199
20.

Comparison of Surgical Outcome After Ahmed Valve Implantation for Patients With and Without Fluocinolone Intravitreal Implant (Retisert).

Hennein L, Hou J, Stewart JM, Lowry EA, Jiang Z, Enanoria WT, Han Y.

J Glaucoma. 2016 Sep;25(9):e772-6. doi: 10.1097/IJG.0000000000000497.

PMID:
27552497

Supplemental Content

Loading ...
Support Center